Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,068 | -75,347 | -41,242 | -20,141 | -255,131 |
| Depreciation Amortization | 1,596 | 1,121 | 673 | 251 | 417 |
| Other Working Capital | 51,717 | 29,214 | 18,512 | 8,005 | -9,522 |
| Other Operating Activity | 6,067 | 3,524 | 1,296 | 468 | 227,726 |
| Operating Cash Flow | $-69,688 | $-41,488 | $-20,761 | $-11,417 | $-36,510 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,040 | -916 | -733 | -676 | -132 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -25,118 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -25,118 |
| Investing Cash Flow | $-1,040 | $-916 | $-733 | $-676 | $-25,250 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 25,000 | 25,000 | 25,000 | 113,174 |
| Common Stock Issued | 89,459 | N/A | 0 | N/A | 191,472 |
| Financing Cash Flow | $114,459 | $25,000 | $25,000 | $25,000 | $304,646 |
| Beginning Cash Position | 243,765 | 243,765 | 243,765 | 243,765 | 879 |
| End Cash Position | 287,496 | 226,361 | 247,271 | 256,672 | 243,765 |
| Net Cash Flow | $43,731 | $-17,404 | $3,506 | $12,907 | $242,886 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,688 | -41,488 | -20,761 | -11,417 | -36,510 |
| Capital Expenditure | -1,040 | -916 | -733 | -676 | -132 |
| Free Cash Flow | -70,728 | -42,404 | -21,494 | -12,093 | -36,642 |